FdaApplication
ANDA 208592
Identifiers
- fda_app_no: ANDA208592
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN LABORATORIES LTD |
| application_type | ANDA |
| approval_date | 2025-05-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| METHYLNALTREXONE BROMIDE | METHYLNALTREXONE BROMIDE | 12MG/0.6ML (12MG/0.6ML) | SOLUTION;SUBCUTANEOUS |
1 product